Aligos therapeutics files response to janssen biopharma lawsuit and lodges counterclaims alleging unfair competition and promissory fraud

South san francisco, calif., sept. 28, 2022 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, has filed a response to the complaint of, and counterclaims against, janssen biopharma in california state superior court for the county of san mateo.
ALGS Ratings Summary
ALGS Quant Ranking